Baxter International Inc. (BAX) Stock Forecast & Price Target
Price as of Nov 17, 2026 close · Analyst estimates retrieved Nov 13, 2026 · Source: Financial Modeling Prep (analyst estimates) (methodology)
Revenue and earnings estimates published by analysts covering Baxter International Inc. (BAX), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.
For Baxter International Inc., analysts forecast revenue falling from $14.74B in 2023 to $12.24B in 2028; the average estimate for 2028 earnings per share is $2.17; with published estimates ranging from $1.38 to $3.42; 12 analysts contribute to these figures. These are forecasts published by analysts, not results.
Analyst price targets
A price target is one analyst's forecast of where a share might trade, usually over twelve months. Targets are frequently revised, they disagree with each other, and they are not a measure of what a company is worth.
Revenue forecast (USD)
The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.
Earnings per share forecast
Baxter International Inc. (BAX) forecast — frequently asked questions
What is the analyst price target for Baxter International Inc.?
Analysts covering Baxter International Inc. (BAX) have a consensus price target of $23.83, 7.5% below the current price of $25.76. Published targets range from $20.00 to $28.00. A price target is a forecast, not a measure of value, and targets are revised often.
What are analysts forecasting for Baxter International Inc.'s earnings?
The average analyst estimate for Baxter International Inc. (BAX) earnings per share in 2028 is 2.17, with individual estimates between 1.38 and 3.42.
How much revenue is Baxter International Inc. expected to make?
Analysts forecast Baxter International Inc. (BAX) revenue of $12.24B in 2028, based on 10 published estimates.
How many analysts cover BAX?
12 analysts contribute estimates for Baxter International Inc. (BAX). Thin coverage makes an average less reliable.
Analyst forecasts for other Medical - Instruments & Supplies stocks
Popular Stocks
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.